Table 5 Comparison of pathological findings between IBDU, UC and CD groups at diagnosis [case n, (%)]
From: Clinical features of inflammatory bowel disease unclassified: a case-control study
| Â | IBDU | UC | p-value | CD | p-value |
|---|---|---|---|---|---|
Patients with endoscopy evaluation | 35 | 59 | Â | 72 | Â |
atypical hyperplasia | 4(11.4%) | 10(16.9%) | 0.467 | 4(5.6%) | 0.489 |
crypt abscess | 21(60.0%) | 51(86.4%) | 0.003 | 27(37.5%) | 0.028 |
granulation tissue | 19(54.3%) | 26(44.1%) | 0.338 | 56(77.8%) | 0.013 |
granuloma | 2(5.7%) | 1(1.7%) | 0.642 | 22(30.6%) | 0.004 |
Patients with colectomies | 12 | 7 | Â | 24 | Â |
fissuring ulcer | 2(16.7%) | 1(14.3%) | 1.000 | 14(58.3%) | 0.032 |
submucosa lymphoid aggregate | 4(33.3%) | 1(14.3%) | 1.000 | 18(75.0%) | 0.029 |
transmural lymphoid aggregate | 2(16.7%) | 0(0.0%) | 0.509 | 14(58.3%) | 0.032 |
transmural inflammation | 9(75.0%) | 0(0.0%) | 0.003 | 18(75.0%) | 1.000 |